KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,065 | +23.4% | 1,846 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $25,992 | -6.0% | 1,846 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $27,653 | +54.6% | 1,846 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,888 | -2.5% | 1,846 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,349 | -67.2% | 1,846 | -61.2% | 0.00% | 0.0% |
| Q4 2021 | $55,943 | +7.4% | 4,753 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $52,086 | -62.7% | 4,573 | -39.4% | 0.00% | -50.0% |
| Q1 2021 | $139,713 | -6.3% | 7,548 | -10.5% | 0.00% | 0.0% |
| Q4 2020 | $149,099 | -5.9% | 8,438 | +35.7% | 0.00% | -33.3% |
| Q2 2020 | $158,409 | – | 6,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |